AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-93
Results: 51-75/93
CLINICAL EFFICACY OF CANCER SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 IN RELATION TO THE PRETREATMENT LEVELS OF TUMOR-GROWTH FACTOR INSULIN-LIKE GROWTH-FACTOR-I
Authors: LISSONI P BARNI S ARDIZZOIA A FRIGERIO F PAOLOROSSI F CAZZANIGA M TANCINI G ROCCO F AAPRO M
Citation: P. Lissoni et al., CLINICAL EFFICACY OF CANCER SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 IN RELATION TO THE PRETREATMENT LEVELS OF TUMOR-GROWTH FACTOR INSULIN-LIKE GROWTH-FACTOR-I, Tumori, 81(4), 1995, pp. 261-264
2ND-LINE THERAPY WITH INTERFERON-ALPHA PLUS VINBLASTINE IN METASTATICRENAL-CELL CANCER-PATIENTS PROGRESSED UNDER INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY
Authors: PAOLOROSSI F VILLA S BARNI S TANCINI G ANDRES M LISSONI P
Citation: F. Paolorossi et al., 2ND-LINE THERAPY WITH INTERFERON-ALPHA PLUS VINBLASTINE IN METASTATICRENAL-CELL CANCER-PATIENTS PROGRESSED UNDER INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY, Tumori, 81(1), 1995, pp. 45-47
PREDICTION OF RECURRENCE IN OPERABLE BREAST-CANCER BY POSTOPERATIVE CHANGES IN PROLACTIN SECRETION
Authors: LISSONI P BARNI S CAZZANIGA M ARDIZZOIA A ROVELLI F TANCINI G BRIVIO F FRIGERIO F
Citation: P. Lissoni et al., PREDICTION OF RECURRENCE IN OPERABLE BREAST-CANCER BY POSTOPERATIVE CHANGES IN PROLACTIN SECRETION, Oncology, 52(6), 1995, pp. 439-442
A BIOLOGICAL STUDY ON THE EFFICACY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN THE TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA
Authors: LISSONI P BARNI S BRIVIO F ROSSINI F FUMAGALLI L ARDIZZOIA A TANCINI G
Citation: P. Lissoni et al., A BIOLOGICAL STUDY ON THE EFFICACY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN THE TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA, Oncology, 52(5), 1995, pp. 360-362
A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES
Authors: BARNI S LISSONI P CAZZANIGA M ARDIZZOIA A MEREGALLI S FOSSATI V FUMAGALLI L BRIVIO F TANCINI G
Citation: S. Barni et al., A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES, Oncology, 52(3), 1995, pp. 243-245
IMMUNOENDOCRINE THERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUSMELATONIN OF LOCALLY ADVANCED OR METASTATIC ENDOCRINE TUMORS
Authors: LISSONI P BARNI S TANCINI G MAININI E PIGLIA F MAESTRONI GJM LEWINSKI A
Citation: P. Lissoni et al., IMMUNOENDOCRINE THERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUSMELATONIN OF LOCALLY ADVANCED OR METASTATIC ENDOCRINE TUMORS, Oncology, 52(2), 1995, pp. 163-166
MODULATION OF CANCER ENDOCRINE THERAPY BY MELATONIN - A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC BREAST-CANCER PATIENTS PROGRESSING UNDER TAMOXIFEN ALONE
Authors: LISSONI P BARNI S MEREGALLI S FOSSATI V CAZZANIGA M ESPOSTI D TANCINI G
Citation: P. Lissoni et al., MODULATION OF CANCER ENDOCRINE THERAPY BY MELATONIN - A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC BREAST-CANCER PATIENTS PROGRESSING UNDER TAMOXIFEN ALONE, British Journal of Cancer, 71(4), 1995, pp. 854-856
A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA
Authors: LISSONI P ARDIZZOIA A MEREGALLI S BARNI S FOSSATI V BRIVIO F TANCINI G
Citation: P. Lissoni et al., A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA, Oncology Reports, 1(6), 1994, pp. 1277-1280
LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY IN ASSOCIATION WITHTHE PINEAL HORMONE MELATONIN AS A FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR-CARCINOMA
Authors: ALDEGHI R LISSONI P BARNI S ARDIZZOIA A TANCINI G PIPERNO A POZZI M RICCI G CONTI A MAESTRONI GJM
Citation: R. Aldeghi et al., LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY IN ASSOCIATION WITHTHE PINEAL HORMONE MELATONIN AS A FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR-CARCINOMA, European journal of cancer, 30A(2), 1994, pp. 167-170
ROLE OF THE PINEAL-GLAND IN THE CONTROL OF MACROPHAGE FUNCTIONS AND ITS POSSIBLE IMPLICATION IN CANCER - A STUDY OF INTERACTIONS BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA AND THE PINEAL HORMONE MELATONIN
Authors: LISSONI P BARNI S TANCINI G BRIVIO F TISI E ZUBELEWICZ B BRACZKOWSKI R
Citation: P. Lissoni et al., ROLE OF THE PINEAL-GLAND IN THE CONTROL OF MACROPHAGE FUNCTIONS AND ITS POSSIBLE IMPLICATION IN CANCER - A STUDY OF INTERACTIONS BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA AND THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 8(4), 1994, pp. 126-129
PRELIMINARY-STUDY ON MODULATION OF THE BIOLOGICAL EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA IN ADVANCED CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN
Authors: BRACKOWSKI R ZUBELEWICZ B ROMANOWSKI W LISSONI P BARNI S TANCINI G MAESTRONI GJM
Citation: R. Brackowski et al., PRELIMINARY-STUDY ON MODULATION OF THE BIOLOGICAL EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA IN ADVANCED CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 8(3), 1994, pp. 77-80
WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS
Authors: LISSONI P BARNI S ARDIZZOIA A FOSSATI V PAOLOROSSI F TANCINI G
Citation: P. Lissoni et al., WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 53-55
WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS
Authors: LISSONI P BARNI S ARDIZZOIA A FOSSATI V PAOLOROSSI F TANCINI G
Citation: P. Lissoni et al., WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 53-55
NORMALIZATION OF IDIOPATHIC ARTERIAL-HYPERTENSION FOLLOWING CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2
Authors: LISSONI P BASTONE A BARNI S TANCINI G GALLI MA
Citation: P. Lissoni et al., NORMALIZATION OF IDIOPATHIC ARTERIAL-HYPERTENSION FOLLOWING CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 65-66
NORMALIZATION OF IDIOPATHIC ARTERIAL-HYPERTENSION FOLLOWING CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2
Authors: LISSONI P BASTONE A BARNI S TANCINI G GALLI MA
Citation: P. Lissoni et al., NORMALIZATION OF IDIOPATHIC ARTERIAL-HYPERTENSION FOLLOWING CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 65-66
A STUDY OF INTERACTIONS AMONG MARKERS OF MACROPHAGE FUNCTIONS IN METASTATIC SOLID TUMORS - NEOPTERIN LEVELS IN RELATION TO THOSE OF TUMOR-NECROSIS-FACTOR-ALPHA AND OF SOLUBLE INTERLEUKIN-2 RECEPTORS
Authors: LISSONI P BRIVIO F FUMAGALLI L GALIMBERTI C CATALDO M MARSILI MT BRIVIO O BARNI S TANCINI G ANGELINI A
Citation: P. Lissoni et al., A STUDY OF INTERACTIONS AMONG MARKERS OF MACROPHAGE FUNCTIONS IN METASTATIC SOLID TUMORS - NEOPTERIN LEVELS IN RELATION TO THOSE OF TUMOR-NECROSIS-FACTOR-ALPHA AND OF SOLUBLE INTERLEUKIN-2 RECEPTORS, Journal of biological regulators and homeostatic agents, 8(1), 1994, pp. 32-35
A RANDOMIZED STUDY OF IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VS CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE CISPLATIN AND ETOPOSIDE AS FIRST-LINE
Authors: LISSONI P MEREGALLI S FOSSATI V PAOLOROSSI F BARNI S TANCINI G FRIGERIO F
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VS CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE CISPLATIN AND ETOPOSIDE AS FIRST-LINE, Tumori, 80(6), 1994, pp. 464-467
LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2
Authors: LISSONI P BARNI S ANDRES M SCARDINO E VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: P. Lissoni et al., LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2, Tumori, 80(4), 1994, pp. 283-285
LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2
Authors: LISSONI P BARNI S ANDRES M SCARDINO E VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: P. Lissoni et al., LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2, Tumori, 80(4), 1994, pp. 283-285
ONDANSETRON DOES NOT STIMULATE PROLACTIN-RELEASE IN BREAST-CANCER PATIENTS
Authors: LISSONI P CAZZANIGA M ROVELLI F MAININI E TANCINI G BARNI S
Citation: P. Lissoni et al., ONDANSETRON DOES NOT STIMULATE PROLACTIN-RELEASE IN BREAST-CANCER PATIENTS, Tumori, 80(3), 1994, pp. 209-211
SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I IN OPERABLE BREAST-CANCER IN RELATION TO THE MAIN PROGNOSTIC VARIABLES AND THEIR PERIOPERATIVECHANGES IN RELATION TO THOSE OF PROLACTIN
Authors: BARNI S LISSONI P BRIVIO F FUMAGALLI L MERLINI D CATALDO M ROVELLI F TANCINI G
Citation: S. Barni et al., SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I IN OPERABLE BREAST-CANCER IN RELATION TO THE MAIN PROGNOSTIC VARIABLES AND THEIR PERIOPERATIVECHANGES IN RELATION TO THOSE OF PROLACTIN, Tumori, 80(3), 1994, pp. 212-215
EFFICACY OF THE CONCOMITANT ADMINISTRATION OF THE PINEAL HORMONE MELATONIN IN CANCER-IMMUNOTHERAPY WITH LOW-DOSE IL-2 IN PATIENTS WITH ADVANCED SOLID TUMORS WHO HAD PROGRESSED ON IL-2 ALONE
Authors: LISSONI P BARNI S CAZZANIGA M ARDIZZOIA A ROVELLI F BRIVIO F TANCINI G
Citation: P. Lissoni et al., EFFICACY OF THE CONCOMITANT ADMINISTRATION OF THE PINEAL HORMONE MELATONIN IN CANCER-IMMUNOTHERAPY WITH LOW-DOSE IL-2 IN PATIENTS WITH ADVANCED SOLID TUMORS WHO HAD PROGRESSED ON IL-2 ALONE, Oncology, 51(4), 1994, pp. 344-347
PROGNOSTIC FACTORS OF THE CLINICAL-RESPONSE TO SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 ALONE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: LISSONI P BARNI S ARDIZZOIA A CRISPINO S PAOLOROSSI F ANDRES M SCARDINO E TANCINI G
Citation: P. Lissoni et al., PROGNOSTIC FACTORS OF THE CLINICAL-RESPONSE TO SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 ALONE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Oncology, 51(1), 1994, pp. 59-62
MELATONIN LEVELS IN PSYCHOGENIC IMPOTENCE
Authors: GRUGNI G CARANI C MAESTRONI G GUZZALONI G ARDIZZI A LISSONI P GRANATA A MORABITO F
Citation: G. Grugni et al., MELATONIN LEVELS IN PSYCHOGENIC IMPOTENCE, Hormone and Metabolic Research, 26(9), 1994, pp. 440-441
COLONY-STIMULATING ACTIVITY AND HEMATOPOIETIC RESCUE FROM CANCER-CHEMOTHERAPY COMPOUNDS ARE INDUCED BY MELATONIN VIA ENDOGENOUS INTERLEUKIN-4
Authors: MAESTRONI GJM CONTI A LISSONI P
Citation: Gjm. Maestroni et al., COLONY-STIMULATING ACTIVITY AND HEMATOPOIETIC RESCUE FROM CANCER-CHEMOTHERAPY COMPOUNDS ARE INDUCED BY MELATONIN VIA ENDOGENOUS INTERLEUKIN-4, Cancer research, 54(17), 1994, pp. 4740-4743
Risultati: 1-25 | 26-50 | 51-75 | 76-93